Hodgkins Lymphoma

17 registered clinical trials studyying Hodgkins Lymphoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Tr NCT05589896	Ossium Health, Inc.	Phase 1 / Phase 2
Withdrawn	(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). NCT05134740	Baylor College of Medicine	Phase 1
Terminated	Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) NCT02603419	Pfizer	Phase 1
Completed	3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma NCT02057445	New York Medical College	Phase 1
Completed	Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment NCT02099266	University of Kansas Medical Center	N/A
Terminated	Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refr NCT01636388	New York Medical College	Phase 2
Completed	Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning NCT01572662	M.D. Anderson Cancer Center	Phase 2
Terminated	Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation NCT01326728	National Cancer Institute (NCI)	—
Terminated	TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation NCT01300611	Tarix Pharmaceuticals	Phase 1
Terminated	Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Bloo NCT00973804	National Cancer Institute (NCI)	Phase 1
Terminated	Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies NCT00837200	Milton S. Hershey Medical Center	Phase 2
Completed	Brown Fat Activity and White Fat Accumulation NCT01517581	Children's Hospital Los Angeles	—
Completed	Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematolo NCT00739141	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	HD18 for Advanced Stages in Hodgkins Lymphoma NCT00515554	University of Cologne	Phase 3
Terminated	Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymph NCT00383097	Baylor College of Medicine	Phase 1
Enrolling By Invitation	Biology Studies of Hematologic Cancers NCT00923442	National Cancer Institute (NCI)	—
Completed	Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma NCT01014507	University of Cologne	Phase 2